Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth

Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Steroids - Volume 129, January 2018, Pages 24-34

Vladimir A. Zolottsev, Yaroslav V. Tkachev, Alexandra S. Latysheva, Vladimir A. Kostin, Roman A. Novikov, Vladimir P. Timofeev, Galina E. Morozevich, Alexey V. Kuzikov, Victoria V. Shumyantseva, Alexander Y. Misharin,